Ascent Capital Group Inc. (NASDAQ:ASCMA): Ahmet Okumus’ Okumus Fund Management filed an amended 13D.
You can check out Okumus Fund Management’s latest holdings and filings here.
Please follow Okumus Fund Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Okumus Fund Management or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Okumus Fund Management Ltd | 0 | 1,027,394 | 0 | 1,027,394 | 1,027,394 | 8.6% |
| Okumus Opportunistic Value Fund, Ltd | 0 | 1,027,394 | 0 | 1,027,394 | 1,027,394 | 8.6% |
| Ahmet H. Okumus | 0 | 1,027,394 | 0 | 1,027,394 | 1,027,394 | 8.6% |
Page 1 of 10 – SEC Filing
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE
13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
| Ascent Capital Group, Inc. |
| (Name of Issuer) |
| Series A Common Stock, $.01 par value |
| (Title of Class of Securities) |
| 043632108 |
| (CUSIP Number) |
| October 17, 2017 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
__________
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
13G Filing: Sabby Capital and Tandem Diabetes Care Inc (TNDM)
13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)
13G Filing: Saba Capital and Templeton Emerging Markets Income Fund (TEI)
13G Filing: Intracoastal Capital, LLC and Aethlon Medical Inc (AEMD)
13G Filing: Tontine Asset Associates, L.L.C. and Global Power Equipment Group...
13G Filing: Biotechnology Value Fund L P and Arqule Inc (ARQL)
